Minor Cannabinoids: Review of Preclinical and Clinical Studies
Education Webinars Minor Cannabinoids: Review of Preclinical and Clinical Studies
This session will focus on the preclinical research and clinical utility of several lesser-known cannabinoids, including cannabigerol (CBG), cannabinol (CBN), cannabidivarin (CBDV), cannabidiolic acid (CBDA), and tetrahydrocannabinolic acid (THCA).
Integrate Powerful Hemp Cannabinoids into your Healthcare Practice
Learn from leading cannabis clinician Bonni Goldstein, MD and grow your practice revenues through our lab-tested hemp extract marketplace, while providing an exclusive medical discount to your patients. For a limited time, our platform is free for licensed US healthcare practitioners only.
With your free account, you'll get access to this educational video and so much more!
This session will focus on the preclinical research and clinical utility of several lesser-known "minor" cannabinoids, including cannabigerol (CBG), cannabinol (CBN), cannabidivarin (CBDV), cannabidiolic acid (CBDA), and tetrahydrocannabinolic acid (THCA). Dr. Bonni will review the latest scientific findings, highlighting the unique pharmacological profiles of these compounds and their potential applications in various medical conditions. Attendees will gain insights into how these minor cannabinoids interact with the endocannabinoid system, other receptors, their safety profiles and their potential to complement or enhance traditional cannabinoid therapies.